Ascelia Pharma (STO:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that two scientific abstracts with clinical data from the SPARKLE Phase ...
AJ Hospital and Research Center is proud to announce the successful liver transplantation for a 62-year-old gentleman, MP, a known case of diabetes and hypertension. The patient presented with ...
The FDA advised that the on-going VIRAGE Phase 2b study should not be expanded into a Phase 3 study; rather, the optimal path forward for the VCN-01 PDAC program is to conduct a stand-alone Phase 3 ...